Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Julphar
Accenture
Deloitte
Cantor Fitzgerald
Cerilliant
McKinsey
Dow
Queensland Health

Generated: July 23, 2018

DrugPatentWatch Database Preview

Levocabastine hydrochloride - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for levocabastine hydrochloride and what is the scope of levocabastine hydrochloride freedom to operate?

Levocabastine hydrochloride
is the generic ingredient in one branded drug marketed by Novartis and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for levocabastine hydrochloride.
Summary for levocabastine hydrochloride
Synonyms for levocabastine hydrochloride
(-)-trans-1-(cis-4-Cyano-4-(p-fluorophenyl)cyclohexyl)-3-methyl-4-phenylisonipecotic acid monohydrochloride
(+-)-trans-1-(cis-4-Cyano-4-(p-fluorophenyl)cyclohexyl)-3-methyl-4-phenylisonipecotic acid
(+-)-trans-1-(cis-4-Cyano-4-(p-fluorophenyl)cyclohexyl)-3-methyl-4-phenylisonipecotic acid.
(3S,4R)-1-(4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid
(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-piperidine-4-carboxylic acid
(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid
(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid hydrochloride
(3S,4R)-1-[cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic Acid Hydrochloride
(3S,4R)-Cabastine Hydrochloride
[3S-[1(cis),3|A,4|A]]-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic acid
[3S-[1(cis),3|A,4|A]]-1-[4-Cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenyl-4-piperidinecarboxylic Acid Monohydrochloride
1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-4-piperidinecarboxylic acid
124XMA6YEI
4-Piperidinecarboxylic acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, (3S-(1(cis),3alpha,4beta))-
4-Piperidinecarboxylic acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, monohydrochloride, (-)-(1(cis),3alpha,4beta)-
4-Piperidinecarboxylic acid, 1-(cis-4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, monohydrochloride, (3S,4R)-
79516-68-0
79516-68-0 (Parent)
79547-78-7
79547-78-7 (hydrochloride)
AB00514704
AB00514704-06
AC1L1GWO
AC1L1GWR
AC1Q1SRD
AJ-23611
AK129788
AKOS016013998
AN-6364
BDBM50019405
Bilina
BPBio1_001382
BRD-K33453211-003-03-2
BSPBio_001257
C-22070
C26H29FN2O2
C26H29FN2O2.HCl
Cabastine [INN]
Cabastinum
CAS-79547-78-7
CCG-221039
CHEBI:135679
CHEBI:31777
CHEBI:92584
CHEMBL1237102
CHEMBL1615438
D01717
D08117
D08SEI
DB01106
DSSTox_CID_25508
DSSTox_GSID_45508
DSSTox_RID_80921
DTXSID1048548
DTXSID9045508
FT-0630869
GTPL1586
H68BP06S81
HE389796
HMS1571O19
Levocabastin
Levocabastina
Levocabastina [Spanish]
levocabastine
Levocabastine (INN)
Levocabastine [INN:BAN]
Levocabastine for system suitability 2, European Pharmacopoeia (EP) Reference Standard
Levocabastine HCl
Levocabastine hydrochloride (JAN/USAN)
Levocabastine hydrochloride [USAN:USP]
Levocabastine hydrochloride [USAN]
Levocabastine hydrochloride, >=99% (HPLC), solid
Levocabastine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Levocabastine hydrochloride, United States Pharmacopeia (USP) Reference Standard
Levocabastinum
Levocabastinum [Latin]
Levocobastine
Levophta
Levostin
Livostin
Livostin (TN)
LS-114668
LS-177481
MLS002154116
MolPort-044-561-796
NCGC00016939-01
NCGC00179240-01
NCGC00179240-02
NCGC00179240-04
Prestwick0_001039
Prestwick1_001039
Prestwick2_001039
Prestwick3_001039
R 50,547
R 50547
R-50547
R50547
SCHEMBL152978
SCHEMBL4577
SCHEMBL99969
SCHEMBL99970
SMR001233423
SPBio_003108
Tox21_110695
Tox21_110695_1
UNII-124XMA6YEI
UNII-COU3RRH769 component ZCGOMHNNNFPNMX-KYTRFIICSA-N
UNII-H68BP06S81
ZINC100089496
ZINC586239

US Patents and Regulatory Information for levocabastine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis LIVOSTIN levocabastine hydrochloride SUSPENSION/DROPS;OPHTHALMIC 020219-001 Nov 10, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cantor Fitzgerald
Dow
Chinese Patent Office
Harvard Business School
Covington
Johnson and Johnson
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.